Close Menu

Enzo

Agendia has hired Neil Barth to be its chief medical officer. Barth has 35 years of experience as a physician and in genomic biomarker development, and he led a staff of 1,400 physicians at Hoag Hospital in Newport Beach, Calif.

Louis Gerstner has been elected chairman of the Broad Institute's board of directors, succeeding outgoing chair Diana Chapman Walsh, who will continue to serve on the board as vice chair.

University of Southern California of Los Angeles has received US Patent No.

NEW YORK (GenomeWeb News) – Enzo Biochem reported after the close of the market Monday that its first-quarter revenues declined 1 percent year over year as a decline in product revenues was offset by growth for its clinical lab services.

Enzo Begins Marketing Dx Test for Early Lung Cancer Detection
Enzo Clinical Labs this week launched a diagnostic test to help oncologists detect lung cancer early and gauge which patients are at heightened risk for disease progression.

NEW YORK (GenomeWeb News) – Life Technologies reported after the close of the market on Thursday that a jury has found it guilty of infringing Enzo Biochem's patents and awarded Enzo $48.6 million.

NEW YORK (GenomeWeb News) – Enzo Biochem announced after the close of the market Monday that its fourth-quarter revenues declined a little more than 1 percent year over year as the firm began a realignment of its operations aimed at reducing its cash burn.

A decade-old string of lawsuits that has embroiled seven life sciences firms is closer to resolution following a recent ruling.

Qiagen has been awarded US Patent No. 8,247,545, "Device and a process for the isolation of nucleic acids."
Metin Colpan is named as inventor on the patent.

Roche, Life Technologies, and Gen-Probe have each filed responses to a lawsuit brought against them by Enzo Life Sciences claiming that various nucleic acid probe-based research and diagnostics products infringe a patent owned by Enzo.

Pages

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.